References
- Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Seroto-nin). Pharmacol Rev 1994;46:157–203.
- Tecott LH, Maricq AV, Julius D. Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc Natl Acad Sci USA 1993;90: 1430–4.
- Werner P, Kawashima E, Reid J, Hussy N, Lundstrom K, Buell G, et al. Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants. Brain Res Mol Brain Res 1994;26:233–41.
- Maricq AV, Peterson AS, Brake AJ, Myers RM, Julius D. Primary structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion channel. Science 1991; 254:432–7.
- Reeves DC, Lummis SC. The molecular basis of the structure and function of the 5-HT3 receptor: a model ligand-gated ion channel (review). Mol Membr Biol 2002;19:11–26.
- Boess FG, Beroukhim R, Martin IL. Ultrastructure of the 5-hydroxytryptamine3 receptor. J Neurochem 1995;64: 1401–5.
- Niesler B, Frank B, Kapeller J, Rappold GA. Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3o HTR3D and HTR3E. Gene 2003;310:101–11.
- van Hooft JA, Yakel JL. 5-HT3 receptors in the CNS: 3B or not 3B? Trends Pharmacol Sci 2003;24: 157–60.
- Greenshaw AJ, Silverstone PH. The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications. Drugs 1997;53:20–39.
- Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scand J Rheumatol 2000;Suppl 113:37–45.
- Norgauer J, Ibig Y, Gmeiner D, Herouy Y, Fiebich BL. Prostaglandin E2 synthesis in human monocyte-derived dendritic cells. Int J Mol Med 2003;12: 83–6.
- Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987;162:156–7.
- Gordon J, Barnes NM. Lymphocytes transport serotonin and dopamine: agony or ecstasy? Trends Immunol 2003;24:438–43.
- Khan NA, Hichami A. Ionotrophic 5-hydroxytryptamine type 3 receptor activates the protein kinase C-dependent phos-pholipase D pathway in human T-cells. Biochem J 1999; 344 Pt. 1:199–204.